Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using electrical stimulation to improve muscle function in stroke patients

Official title: The Application of Wide Pulse High Frequency Neuromuscular Electrical Stimulation in Disorders Associated With Motoneuron Hyperexcitability

Run by University of Lausanne · NCT05908214 · Data updated 2026-11-12

This study is testing if a special type of electrical stimulation can help stroke patients improve their muscle control and mobility.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment110 (estimated)
SponsorUniversity of Lausanne
Academic / other
Locations1 site (Lausanne)
StatusRecruiting
StartedOctober 1, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedNovember 28, 2023
Trial IDNCT05908214 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are stroke patients with unilateral motor deficits who have been diagnosed at least 6 months prior and exhibit specific ankle control issues.

Probably not a fit

Patients with surface sensory loss in the affected lower leg or those unable to understand study instructions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the use of wide pulse high frequency neuromuscular electrical stimulation (WPHF NMES) to address motoneuron hyperexcitability and its associated impairments in conditions like stroke, muscle cramps, and restless legs syndrome. The study aims to understand the underlying mechanisms of these conditions and utilize WPHF NMES as a training method to enhance neuromuscular function in stroke patients. Participants will undergo electrical stimulation training to improve their ankle control and overall mobility.

Why it matters

Potential benefit: If successful, this approach could significantly improve muscle strength and mobility in stroke patients.

How similar studies have gone: While the approach is innovative, similar studies using neuromuscular electrical stimulation have shown promise in improving muscle function in various conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
STROKE PATIENTS:

* Diagnosis of first-ever stroke (ischemic or hemorrhagic) with unilateral motor deficits from at least 6 months. Stroke will have to be confirmed from medical records and/or radiological imaging (CT scan or MRI)
* Inadequate ankle control during gait defined as ankle dorsiflexion less than 5° during stance phase and 0° during swing phase; 0° = ankle neutral position)
* Passive range of motion of ankle dorsiflexion at least to neutral position
* Ability to walk at least 10 m with or without assistive devices
* Spasticity at the triceps surae (either soleus and/or gastrocnemii) considered as a Modified Ashworth Sore ≥1
* Being available for the study period and willing to participate
* No contraindication to neuromuscular electrical stimulation

Contraindications for stroke patients:

* Surface sensory loss of affected lower leg (defined as incapacity to feel the 60-g touch using the Semmes-Weinstein monofilament test)
* Patients unable to understand indications or to provide informed consent
* A history of orthopedic or other neurological disorders affecting walking function
* A history of surgery to correct drop foot (ankle fixation)
* Patients under antispastic medication (baclofen, tizanidine, tolperisone, benzodiazepines, dantrolene or botulinum toxin to the plantar flexor muscles in the last 6 months).

PEOPLE PRONE TO MUSCLE CRAMPS:

* Reporting nocturnal muscle cramps (the assessment will be done through a questionnaire)
* Not being treated for muscle cramps
* Being available for the study period and willing to participate
* No contraindication to neuromuscular electrical stimulation

PATIENTS WITH RESTLESS LEGS SYNDROME:

To be included in the study, RLS patients will have to satisfy the Diagnostic criteria for RLS published by the International Restless Legs Syndrome StudyGroup (IRLSSG). All five key clinical features are required for the diagnosis:

* An urge to move the legs, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs. Sometimes the urge to move is present without the uncomfortable sensations, and sometimes the arms or other body parts are involved in addition to the legs.
* The urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as lying or sitting.
* The urge to move or unpleasant sensations are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues.
* The urge to move or unpleasant sensations are worse in the evening or night than during the day, or only occur in the evening or night. When symptoms are severe, the worsening at night may not be noticeable but must have been previously present.
* Symptoms are not solely accounted for by another medical or behavioral condition, such as leg cramps or habitual foot tapping.
* No contraindication to neuromuscular electrical stimulation

They will also have to satisfy the following criteria:

* Diagnosis of primary RLS corresponding to:

  1. The presence of periodic limb movements
  2. A dopaminergic treatment response
  3. The presence of RLS in first-degree relatives
  4. A lack of profound daytime sleepiness
* Being available for the study period and willing to participate

HEALTHY PARTICIPANTS:

* No neurological disease
* No contraindication to neuromuscular electrical stimulation
* Being available for the study period and willing to participate

Where it's running

  • Bâtiment Synathlon, quartier UNIL-Centre
    Lausanne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.